Search Results - "Sitkovsky, Michail V."

Refine Results
  1. 1
  2. 2

    Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells by Sethumadhavan, Shalini, Silva, Murillo, Philbrook, Phaethon, Nguyen, Thao, Hatfield, Stephen M, Ohta, Akio, Sitkovsky, Michail V

    Published in PloS one (20-11-2017)
    “…Human cancers are known to downregulate Major Histocompatibility Complex (MHC) class I expression thereby escaping recognition and rejection by anti-tumor T…”
    Get full text
    Journal Article
  3. 3

    Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia by Sitkovsky, Michail V, Kjaergaard, Jorgen, Lukashev, Dmitriy, Ohta, Akio

    Published in Clinical cancer research (01-10-2008)
    “…Cancerous tissue protection from tumor-recognizing CD8 + and CD4 + T cells (antitumor T cells) limits the therapeutic potential of immunotherapies. We propose…”
    Get full text
    Journal Article
  4. 4

    Immunomodulatory and neuroprotective effects of inosine by Haskó, György, Sitkovsky, Michail V., Szabó, Csaba

    “…Adenosine has been considered as a potential immunomodulatory and neuroprotective agent for 30 years. Inosine, a major degradation product of adenosine, was…”
    Get full text
    Journal Article
  5. 5

    Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes by Silva, Murillo, Nguyen, Thao H., Philbrook, Phaethon, Chu, Matthew, Sears, Olivia, Hatfield, Stephen, Abbott, Robert K., Kelsoe, Garnett, Sitkovsky, Michail V.

    Published in Cell reports (Cambridge) (26-12-2017)
    “…Rapidly evolving pathogens such as HIV or influenza can quickly mutate their antigenic profiles, reducing the efficacy of conventional vaccines. Despite this…”
    Get full text
    Journal Article
  6. 6

    Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury by Thiel, Manfred, Chouker, Alexander, Ohta, Akio, Jackson, Edward, Caldwell, Charles, Smith, Patrick, Lukashev, Dmitry, Bittmann, Iris, Sitkovsky, Michail V

    Published in PLoS biology (01-06-2005)
    “…Acute respiratory distress syndrome (ARDS) usually requires symptomatic supportive therapy by intubation and mechanical ventilation with the supplemental use…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo by Gomez, Gregorio, Sitkovsky, Michail V.

    Published in Blood (15-12-2003)
    “…Inosine is an endogenous nucleoside with immunosuppressive properties that is known to inhibit the accumulation of proinflammatory cytokines and protect mice…”
    Get full text
    Journal Article
  9. 9

    Mechanisms of Disease: Purinergic Signaling during Inflammation by Eltzschig, Holger K, Sitkovsky, Michail V, Robson, Simon C

    Published in The New England journal of medicine (13-12-2012)
    “…Receptors for ATP and ADP and adenosine exert various effects. ATP and ADP signaling is mainly proinflammatory, and adenosine signaling is mainly…”
    Get full text
    Journal Article
  10. 10

    Purinergic Signaling during Inflammation by Eltzschig, Holger K, Sitkovsky, Michail V, Robson, Simon C

    Published in The New England journal of medicine (13-12-2012)
    “…Receptors for ATP and ADP and adenosine exert various effects. ATP and ADP signaling is mainly proinflammatory, and adenosine signaling is mainly…”
    Get full text
    Journal Article
  11. 11

    Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy by Hatfield, Stephen M, Sitkovsky, Michail V

    Published in The Journal of clinical investigation (01-11-2020)
    “…Hypoxia/HIF-1α- and extracellular adenosine/A2 adenosine receptor-mediated immunosuppression protects tissues from collateral damage by antipathogen immune…”
    Get full text
    Journal Article
  12. 12

    Differential regulation of HIF-1α isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists by Ramanathan, Madhuri, Luo, Wenting, Csóka, Balázs, Haskó, György, Lukashev, Dmitry, Sitkovsky, Michail V., Leibovich, Samuel Joseph

    Published in Journal of leukocyte biology (01-09-2009)
    “…Up‐regulation of adenosine A2A receptors (A2ARs) and the HIF‐1αl. 1 isoform plays an important role in the switch of macrophages from an inflammatory (M1) to…”
    Get full text
    Journal Article
  13. 13

    The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases by THIEL, Manfred, CALDWELL, Charles C, SITKOVSKY, Michail V

    Published in Microbes and infection (01-05-2003)
    “…Adenosine can be described as a retaliatory metabolite, the production and release of which is usually enhanced under adverse environmental conditions. Binding…”
    Get full text
    Journal Article
  14. 14

    T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response by Sitkovsky, Michail V

    Published in Trends in immunology (01-03-2009)
    “…T regulatory cells (Treg cells) suppress immune responses to maintain self tolerance, but they also protect cancerous tissues. I propose a model to potentially…”
    Get full text
    Journal Article
  15. 15

    Sufficient numbers of anti-tumor T cells is a condition of maximal efficacy of anti-hypoxia-A2-adenosinergic drugs during cancer immunotherapy by Sitkovsky, Michail V

    Published in Current opinion in pharmacology (01-08-2020)
    “…•Discoveries of hypoxia-adenosine pathway and credit to teams of contributing authors.•Limitation of anti-hypoxia-adenosinergic treatments in…”
    Get full text
    Journal Article
  16. 16

    Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists by Sitkovsky, Michail V, Hatfield, Stephen, Abbott, Robert, Belikoff, Bryan, Lukashev, Dmitriy, Ohta, Akio

    Published in Cancer immunology research (01-07-2014)
    “…Hypoxia-driven, A2A adenosine receptor (A2AR)-mediated (hypoxia-A2-adenosinergic), T-cell-autonomous immunosuppression was first recognized as critical and…”
    Get more information
    Journal Article
  17. 17

    Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor by Moriyama, Kengo, Sitkovsky, Michail V.

    Published in The Journal of biological chemistry (10-12-2010)
    “…The A2A and A2B adenosine receptors (A2AR and A2BR) are implicated in many physiological processes. However, the mechanisms of their intracellular maturation…”
    Get full text
    Journal Article
  18. 18

    Oxygen‐Generating Cryogels Restore T Cell Mediated Cytotoxicity in Hypoxic Tumors by Colombani, Thibault, Eggermont, Loek J., Hatfield, Stephen M., Rogers, Zachary J., Rezaeeyazdi, Mahboobeh, Memic, Adnan, Sitkovsky, Michail V., Bencherif, Sidi A.

    Published in Advanced functional materials (01-09-2021)
    “…Solid tumors are protected from antitumor immune responses due to their hypoxic microenvironments. Weakening hypoxia‐driven immunosuppression by hyperoxic…”
    Get full text
    Journal Article
  19. 19

    Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors by Sitkovsky, Michail V, Lukashev, Dmitriy, Apasov, Sergey, Kojima, Hidefumi, Koshiba, Masahiro, Caldwell, Charles, Ohta, Akio, Thiel, Manfred

    Published in Annual review of immunology (2004)
    “…Immune cell-mediated destruction of pathogens may result in excessive collateral damage to normal tissues, and the failure to control activated immune cells…”
    Get full text
    Journal Article
  20. 20

    Use of the A 2A adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo by Sitkovsky, Michail V

    Published in Biochemical pharmacology (15-02-2003)
    “…Inflammation must be inhibited in order to treat, e.g., sepsis or autoimmune diseases or must be selectively enhanced to improve, for example, immunotherapies…”
    Get full text
    Journal Article